T. Rowe Price Associates’s GenMark Diagnostics, Inc GNMK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $4.33M | Sell |
|
|||||
|
2020
Q4 | $27.3M | Sell |
|
|||||
|
2020
Q3 | $27.2M | Sell |
|
|||||
|
2020
Q2 | $28.6M | Sell |
|
|||||
|
2020
Q1 | $8.73M | Buy |
|
|||||
|
2019
Q4 | $10.2M | Sell |
|
|||||
|
2019
Q3 | $18.2M | Sell |
|
|||||
|
2019
Q2 | $42.8M | Sell |
|
|||||
|
2019
Q1 | $54.5M | Sell |
|
|||||
|
2018
Q4 | $39.6M | Sell |
|
|||||
|
2018
Q3 | $63.6M | Sell |
|
|||||
|
2018
Q2 | $56.5M | Sell |
|
|||||
|
2018
Q1 | $48.4M | Buy |
|
|||||
|
2017
Q4 | $36.8M | Buy |
|
|||||
|
2017
Q3 | $63.5M | Buy |
|
|||||
|
2017
Q2 | $58.7M | Buy |
|
|||||
|
2017
Q1 | $51.4M | Buy |
|
|||||
|
2016
Q4 | $47.5M | Buy |
|
|||||
|
2016
Q3 | $44.5M | Buy |
|
|||||
|
2016
Q2 | $23.2M | Sell |
|
|||||
|
2016
Q1 | $14.1M | Buy |
|
|||||
|
2015
Q4 | $20M | Buy |
|
|||||
|
2015
Q3 | $19.9M | Sell |
|
|||||
|
2015
Q2 | $23.2M | Buy |
|
|||||
|
2015
Q1 | $33.3M | Sell |
|
|||||
|
2014
Q4 | $35M | Sell |
|
|||||
|
2014
Q3 | $23.2M | Buy |
|
|||||
|
2014
Q2 | $34.9M | Sell |
|
|||||
|
2014
Q1 | $26.4M | Buy |
|
|||||
|
2013
Q4 | $35.3M | Sell |
|
|||||
|
2013
Q3 | $51.2M | Buy |
|
|||||
|
2013
Q2 | $40.3M | Buy |
|